Study on aberrant DNA hypermethylation in HNSCC

碩士 === 國立陽明大學 === 臨床牙醫學研究所 === 97 === Background: Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide. Of HNSCC patients, recurrence and metastasis are common even after treatment and usually results in poor prognosis. Hypermethylation of CpG islands in promoter r...

Full description

Bibliographic Details
Main Authors: Wei-Li Huang, 黃偉立
Other Authors: Shou-Yen Kao, Prof.
Format: Others
Language:zh-TW
Published: 2009
Online Access:http://ndltd.ncl.edu.tw/handle/57928066603552128499
id ndltd-TW-097YM005594003
record_format oai_dc
spelling ndltd-TW-097YM0055940032016-05-04T04:16:31Z http://ndltd.ncl.edu.tw/handle/57928066603552128499 Study on aberrant DNA hypermethylation in HNSCC 頭頸部鱗狀上皮細胞癌異常基因甲基化之研究 Wei-Li Huang 黃偉立 碩士 國立陽明大學 臨床牙醫學研究所 97 Background: Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide. Of HNSCC patients, recurrence and metastasis are common even after treatment and usually results in poor prognosis. Hypermethylation of CpG islands in promoter region of tumor suppressor genes is well-demonstrated in cancers and is under development to act as biomarkers for cancer risk assessment. This study aims to investigate the feasibility of DNA methylation-based marker for HNSCC prognosis. Methods: We examined promoter hypermethylation of p16, glutathione S-transferase pi (GSTP1), O6-methylguanine-DNA methyltransferase (MGMT), death-associated protein kinase 1 (DAPK1), RAS-association domain family 1, isoform A (RASSF1A), and E-cadherin (CDH1) genes of 33 HNSCCs paired with adjacent non-tumorous tissues using qualitative methylation-specific PCR (Q-MSP). Of p16 allele, 52 tumors of HNSCC were assayed. Results: Hypermethylation of test promoters was irrelative to gender, stage, recurrence, and differentiation. However, hypermethylation of p16 promoter in tumors was significantly correlated with metastatic lymph node (p=0.003), distant metastasis (p=0.001), or younger patients (p=0.027). Patients with hypermethylated p16 allele have higher risk for distant metastasis than those without (OR=15.3). Of overall survival status, histopathological differentiation grade, recurrence, or distant metastasis was linked to poor diagnosis (p < 0.001, Log rank test). Hypermethylation of p16INK4a promoter was significantly associated with increased distant metastasis (p=0.001) and shortened disease-free time in HNSCC patients older than 52 (p=0.034). Conclusions: This study shows that p16 hypermethylation correlates with increased invasiveness of HNSCC and decreased survival in an age-dependent manner. Our findings not only suggest the potential prognostic value of p16 hypermethylation but also indicate the involvement of p16 with cell migration in HNSCC carcinogenesis. Shou-Yen Kao, Prof. Pei-Fen Su, Ph.D. 高壽延 蘇佩芬 2009 學位論文 ; thesis 58 zh-TW
collection NDLTD
language zh-TW
format Others
sources NDLTD
description 碩士 === 國立陽明大學 === 臨床牙醫學研究所 === 97 === Background: Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide. Of HNSCC patients, recurrence and metastasis are common even after treatment and usually results in poor prognosis. Hypermethylation of CpG islands in promoter region of tumor suppressor genes is well-demonstrated in cancers and is under development to act as biomarkers for cancer risk assessment. This study aims to investigate the feasibility of DNA methylation-based marker for HNSCC prognosis. Methods: We examined promoter hypermethylation of p16, glutathione S-transferase pi (GSTP1), O6-methylguanine-DNA methyltransferase (MGMT), death-associated protein kinase 1 (DAPK1), RAS-association domain family 1, isoform A (RASSF1A), and E-cadherin (CDH1) genes of 33 HNSCCs paired with adjacent non-tumorous tissues using qualitative methylation-specific PCR (Q-MSP). Of p16 allele, 52 tumors of HNSCC were assayed. Results: Hypermethylation of test promoters was irrelative to gender, stage, recurrence, and differentiation. However, hypermethylation of p16 promoter in tumors was significantly correlated with metastatic lymph node (p=0.003), distant metastasis (p=0.001), or younger patients (p=0.027). Patients with hypermethylated p16 allele have higher risk for distant metastasis than those without (OR=15.3). Of overall survival status, histopathological differentiation grade, recurrence, or distant metastasis was linked to poor diagnosis (p < 0.001, Log rank test). Hypermethylation of p16INK4a promoter was significantly associated with increased distant metastasis (p=0.001) and shortened disease-free time in HNSCC patients older than 52 (p=0.034). Conclusions: This study shows that p16 hypermethylation correlates with increased invasiveness of HNSCC and decreased survival in an age-dependent manner. Our findings not only suggest the potential prognostic value of p16 hypermethylation but also indicate the involvement of p16 with cell migration in HNSCC carcinogenesis.
author2 Shou-Yen Kao, Prof.
author_facet Shou-Yen Kao, Prof.
Wei-Li Huang
黃偉立
author Wei-Li Huang
黃偉立
spellingShingle Wei-Li Huang
黃偉立
Study on aberrant DNA hypermethylation in HNSCC
author_sort Wei-Li Huang
title Study on aberrant DNA hypermethylation in HNSCC
title_short Study on aberrant DNA hypermethylation in HNSCC
title_full Study on aberrant DNA hypermethylation in HNSCC
title_fullStr Study on aberrant DNA hypermethylation in HNSCC
title_full_unstemmed Study on aberrant DNA hypermethylation in HNSCC
title_sort study on aberrant dna hypermethylation in hnscc
publishDate 2009
url http://ndltd.ncl.edu.tw/handle/57928066603552128499
work_keys_str_mv AT weilihuang studyonaberrantdnahypermethylationinhnscc
AT huángwěilì studyonaberrantdnahypermethylationinhnscc
AT weilihuang tóujǐngbùlínzhuàngshàngpíxìbāoáiyìchángjīyīnjiǎjīhuàzhīyánjiū
AT huángwěilì tóujǐngbùlínzhuàngshàngpíxìbāoáiyìchángjīyīnjiǎjīhuàzhīyánjiū
_version_ 1718255983306735616